28 related articles for article (PubMed ID: 8796884)
1. Correlation of selective modifications to a 2',5'-oligoadenylate-3',5'-deoxyribonucleotide antisense chimera with affinity for the target nucleic acid and with ability to activate RNase L.
Xiao W; Li G; Maitra RK; Maran A; Silverman RH; Torrence PF
J Med Chem; 1997 Apr; 40(8):1195-200. PubMed ID: 9111293
[TBL] [Abstract][Full Text] [Related]
2. 2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection.
Barnard DL; Sidwell RW; Xiao W; Player MR; Adah SA; Torrence PF
Antiviral Res; 1999 Apr; 41(3):119-34. PubMed ID: 10320045
[TBL] [Abstract][Full Text] [Related]
3. Discrimination between ribonuclease H- and ribonuclease L-mediated RNA degradation by 2'-O-methylated 2-5A-antisense oligonucleotides.
Cramer H; Player MR; Torrence PF
Bioorg Med Chem Lett; 1999 Apr; 9(7):1049-54. PubMed ID: 10230638
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of the antisense oligonucleotides carrying the modified 2-5A molecules at their 5'-termini and their properties.
Ueno Y; Kato Y; Okatani S; Kitade Y
Nucleic Acids Res Suppl; 2002; (2):45-6. PubMed ID: 12903097
[TBL] [Abstract][Full Text] [Related]
5. Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells.
Cirino NM; Li G; Xiao W; Torrence PF; Silverman RH
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1937-42. PubMed ID: 9050883
[TBL] [Abstract][Full Text] [Related]
6. RNase L and 2-5A to enhance antisense technology and target the destruction of mRNA.
Glaser V
Mol Med Today; 1996 May; 2(5):183. PubMed ID: 8796884
[No Abstract] [Full Text] [Related]
7. Controlling gene expression with 2-5A antisense.
Leaman DW; Cramer H
Methods; 1999 Jul; 18(3):252-65. PubMed ID: 10454983
[TBL] [Abstract][Full Text] [Related]
8. Recruiting the 2-5A system for antisense therapeutics.
Torrence PF; Xiao W; Li G; Cramer H; Player MR; Silverman RH
Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):203-6. PubMed ID: 9212911
[No Abstract] [Full Text] [Related]
9. The 2-5A/RNase L pathway and inhibition by RNase L inhibitor (RLI).
Bisbal C; Salehzada T; Silhol M; Martinand C; Le Roy F; Lebleu B
Methods Mol Biol; 2001; 160():183-98. PubMed ID: 11265282
[No Abstract] [Full Text] [Related]
10. Antisense oligoribonucleotides and RNase P. A great potential.
Krupp G
Biochimie; 1993; 75(1-2):135-9. PubMed ID: 7684934
[TBL] [Abstract][Full Text] [Related]
11. The 2-5A system in viral infection and apoptosis.
Castelli J; Wood KA; Youle RJ
Biomed Pharmacother; 1998; 52(9):386-90. PubMed ID: 9856285
[TBL] [Abstract][Full Text] [Related]
12. Antisense technology: a selective tool for gene expression regulation and gene targeting.
Sahu NK; Shilakari G; Nayak A; Kohli DV
Curr Pharm Biotechnol; 2007 Oct; 8(5):291-304. PubMed ID: 17979727
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]